A Lipid Panel Taken After a Heart Attack or Stroke
Cholesterol falls within a day or two of a major acute event and stays down for weeks, so a panel taken during the admission reports a level well below your usual one. The risk is not the number itself but what follows from it: treatment intensity set against an artificially low reading, at exactly the point when getting it right matters most.
The pattern on your report
- LDL cholesterol Normal Key
- Total cholesterol Normal Key
- Triglycerides High-normal Key
- CRP High Key
Printed as: CRP in mg/Lor mg/dL— The context. A markedly raised value beside an improved cholesterol identifies the effect.LDL cholesterol in mmol/Lor mg/dL— Falls from about a day after a major acute event and takes weeks to return, so an in-hospital value understates the usual level.Total cholesterol in mmol/Lor mg/dLTriglycerides in mmol/Lor mg/dL— Often moves the opposite way, rising with the same inflammatory drive that lowers the cholesterol.
Why the numbers look like this
A heart attack, a stroke, major surgery or a severe infection all trigger an acute phase response. The liver switches its production toward inflammatory proteins and away from lipoproteins, and clearance from the blood changes at the same time.
The result is a measurable fall in total and LDL cholesterol beginning within about 24 hours, deepening over the following days, and taking weeks to return to baseline. Triglycerides often move the other way, rising with the same inflammatory drive.
This is why guidelines advise measuring on admission, before the effect has developed, and why a level taken on day three of a hospital stay is not the level to plan long-term treatment around.
The same reasoning applies to the decision to start treatment at all. After a cardiovascular event, lipid-lowering treatment is started because of the event, not because of the number, so a reassuring-looking panel is not a reason to withhold it.
Not being flagged is not the same as normal
The thresholds printed on the report are drawn for people in a stable state, and they describe risk in that setting and not during an acute illness. A CRP taken at the same time usually makes the situation obvious, since a markedly raised inflammatory response alongside a suddenly improved cholesterol is the signature of the effect rather than of anything having changed for the better. Where a genuine baseline is needed, a panel taken 6 to 8 weeks after recovery is the one to plan from.
What else on the report can hide this
Look for a lipid result from before the event. A panel from six months earlier is far more useful than one taken in hospital, and it frequently exists.
CRP taken at the same time places the reading in context, and a raised value alongside a low cholesterol identifies the effect immediately.
Repeating once recovered establishes the true baseline, and it shows whether the treatment started is achieving what it should. NICE recommends checking the lipid profile 2 to 3 months after starting or changing lipid-lowering treatment, which fits naturally alongside recovery.
A TSH is worth including in that later round, since an underactive thyroid raises cholesterol and is commonly found at this point.
The practical message is worth being direct about: after a cardiovascular event the decision to treat does not depend on the cholesterol level, so a low reading during admission changes nothing about whether treatment starts. What it can change, wrongly, is how hard the treatment aims — which is why the later panel matters.
What usually causes it
Listed from most to least common — not from most to least serious.
- Very common
The acute phase response
Cholesterol falls from about 24 hours after the event and takes weeks to recover. A raised CRP alongside makes it obvious.
- Very common
A sample taken days into an admission
The effect deepens over the first days, so timing within the stay determines how misleading the value is.
- Common
Statin already started in hospital
Treatment begun on admission lowers the level further, so a panel taken later reflects both effects at once.
- Common
Major surgery or severe infection
The same response from a different trigger. Any severe illness produces it.
- Common
A genuinely low cholesterol
Events happen in people whose lipids were never high, which is why treatment after an event does not depend on the number.
- Uncommon
Poor intake during the illness
Contributes on top of the acute phase effect, particularly during a prolonged stay.
- Uncommon
Heart failure
Lowers cholesterol independently and persistently, so the level may not return to the previous baseline.
- Uncommon
An underactive thyroid found afterwards
Raises cholesterol, so it can mask the acute fall and then reveal itself on the later panel.
What is usually checked next
- Any lipid result from before the event A panel from months earlier describes the true baseline better than anything measured in hospital.
- CRP from the same sample A markedly raised value alongside a low cholesterol identifies the acute phase effect at once.
- Repeat the panel 6 to 8 weeks after recovery Establishes the real baseline and whether treatment is achieving what it should.
- Non-HDL cholesterol on the later panel The value guidelines set the target on, and it does not require fasting.
- TSH An underactive thyroid raises cholesterol and is frequently identified at this point.
When to seek care sooner
- Emergency Chest pain, or breathlessness at rest
- Emergency Weakness or numbness on one side, or difficulty speaking
- Same day Severe muscle pain and weakness after starting a statin
- Same day Swelling of the legs with increasing breathlessness
- Soon Being told treatment is unnecessary because cholesterol is normal
- Soon No repeat panel arranged after discharge
Questions worth bringing to your appointment
- Do I have a cholesterol result from before this happened?
- How many days into the admission was this sample taken?
- Was my CRP raised at the same time?
- When should the panel be repeated to get a true baseline?
- Does treatment depend on the number, or on the event?